NEW YORK (GenomeWeb News) – The Beijing Genome Institute and the Danish diagnostic developer PentaBase have agreed to co-develop disease detection kits using genetic biomarkers, PentaBase said today.
 
The agreement expands an ongoing collaboration with SD Genomics, which serves as BGI’s contact point in Denmark, that is focused on developing and launching real-time PCR-based diagnostics kits.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.